Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium.
Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium.
复制标题
北美儿科血液和骨髓移植研究的进展：儿科血液和骨髓移植联盟的优先事项。
DOI：
10.1016/j.bbmt.2009.12.536
复制
发表时间：
2010
期刊：
影响因子：
--
通讯作者：
Gardner
中科院分区：
文献类型：
--
作者：
Pulsipher,MichaelA;Horwitz,EdwinM;Haight,AnnE;Kadota,Richard;Chen,AllenR;Frangoul,Haydar;Cooper,LaurenceJN;Jacobsohn,DavidA;Goyal,RakeshK;Mitchell,David;Nieder,MichaelL;Yanik,Gregory;Cowan,MortonJ;Soni,Sandeep;Gardner
Advances in pediatric blood and marrow transplantation (BMT) are slowed by the small number of patients with a given disease who undergo transplantation, a lack of sufficient infrastructure to run early-phase oncology protocols and studies of rare nonmalignant disorders, and challenges associated with funding multi-institutional trials. Leadership of the Pediatric Blood and Marrow Transplant Consortium (PBMTC), a large pediatric BMT clinical trials network representing 77 active and 45 affiliated centers worldwide, met in April 2009 to develop strategic plans to address these issues. Key barriers, including infrastructure development and funding, along with scientific initiatives in malignant and nonmalignant disorders, cellular therapeutics, graft-versus-host disease, and supportive care were discussed. The PBMTC's agenda for approaching these issues will result in infrastructure and trials specific to pediatrics that will run through the PBMTC or its partners, the Blood and Marrow Transplant Clinical Trials Network and the Children's Oncology Group.
